Recipients and donors in living-kidney transplantation
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are scheduled living-kidney transplantation as recipients or donors in Kagawa University Hospital and agreed with the study
Exclusion criteria
Exclusion criteria: 1)Kidney transplant from cadaver donors or brain-dead donors. 2)Patients who are under 16 years-old 3)Patients without agreement 4)Patients inadequate for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)AGT (urine and serum),soluble (pro) renin receptor (urine and serum) and plasma AMDA: 0,12,36,60 months 2)Senescence-associated beta galactosidase and arteriosclerosis in donated kidney or allograft: 0,12,36,60 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Cr and eGFR in donors and recipients: 0,6,12,24,36,48,60 months 2)CAVI and central BP: 0,12,36,60 months 3)urinary albumin, proteinuria and urinary occult blood: 0,6,12,24,36,48,60 months 4)patient survival rates, allograft survival rates and cardiovascular events: 0-60months 5)BP: 0,6,12,24,36,48,60 months | — |
Countries
Japan
Contacts
Kagawa University, Faculty of Medicine Department of Cardiorenal and Cerebrovascular Medicine